Frovatriptan succinate hydrate

Mfr.No.	T11326
Description	Frovatriptan succinate hydrate (Frova) is effective in treating the full spectrum of migraine including the associated symptoms of nausea, vomiting, photophobia, and phonophobia. Frovatriptan succinate hydrate can also be used as in mini-prophylaxis in menstrual migraine. Frovatriptan succinate hydrate is a potent, high affinity, selective and orally active 5-HT1B, HT1D receptor agonist and a moderately potent 5-HT7 receptor agonist, with pKi values of 8.6, 8.4, and 6.7, respectively.
Alternative Names	Frova
Molecular Formula	C18H25N3O6
Signaling Pathways	GPCR/G Protein, Neuroscience
Smiles	O=C(O)CCC(O)=O.O=C(C1=CC2=C(NC3=C2C(CH)(NC)CC3)C=C1)N.O
Cas Number	158930-17-7
Molecular Weight	379.41
Target	5-HT Receptor

Have you used this product?

SKU	Supplier No.	Size	Your price
BHB20402020	T11326	1 mL	$54	Add to Cart
BHB20402020	T11326	2 mg	$30	Add to Cart
BHB20402020	T11326	5 mg	$48	Add to Cart
BHB20402020	T11326	10 mg	$80	Add to Cart
BHB20402020	T11326	25 mg	$147	Add to Cart
BHB20402020	T11326	50 mg	$218	Add to Cart
BHB20402020	T11326	100 mg	$323	Add to Cart